| 2009 | Ozone Induces Pulmonary Fibrosis via a TGF-beta Signaling Pathway | 김대기 | Meeting Abstract |
| 2015 | Synthesis and biological evaluation of 5-(fluoro-substituted-6-methylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-alpha]pyridin-6-yl)imidazoles as inhibitors of transforming growth factor-beta type I receptor kinase | 신윤용; 김대기 | Article |
| 2016 | TGF-β type i receptor kinase inhibitor EW-7197 suppresses cholestatic liver fibrosis by inhibiting HIF1α-induced epithelial mesenchymal transition | 신윤용; 김대기 | Article |
| 2007 | Development of 4(5)-(6-alkylpyridin-2-yl)imidazoles as transforming growth factor-beta type1 receptor kinase inhibitors as anti-fibrotic agents | 김대기 | Meeting Abstract |
| 2023 | Beneficial Effects of a Curcumin Derivative and Transforming Growth Factor-β Receptor I Inhibitor Combination on Nonalcoholic Steatohepatitis | 김대기 | Article |
| 2008 | Effect of IN-1130, a Small Molecule Inhibitor of Transforming Growth Factor-beta Type I Receptor/Activin Receptor-Like Kinase-5, on Prostate Cancer Cells | 신윤용; 김대기 | Article |
| 2008 | DISTRIBUTION AND METABOLISM OF NEW ALK-5 INHIBITOR, IN-1130 | 신윤용; 김대기 | Meeting Abstract |
| 2009 | Altered bone morphogenetic protein and transforming growth factor-β signaling in rat models of pulmonary hypertension. Potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease | 김대기 | Article |
| 2006 | Synthesis of 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazin-1-ylsulfonyl]-2-n- propoxyphenyl}-7-n-propyl-3,5-dihydro-4H-pyrrolo[3,2-d]-[2-14C] pyrimidin-4-one · 2 HCl (14C-SK3530 · 2 HCl) | 김대기 | Article |
| 2012 | Synthesis and biological evaluation of 2-benzylamino-4(5)-(6-methylpyridin- 2-yl)-5(4)-([1,2,4]triazolo[1,5-a]-pyridin-6-yl)thiazoles as transforming growth factor-β type 1 receptor kinase inhibitors | 신윤용; 김대기; 김승원 | Article |
